Selective inhibitors in the knockout mouse model for severe chronic obstructive pulmonary disorder (COPD) have established the beneficial anti-inflammatory effect of PDE4B to improve lung function and decrease exacerbation rates. This evidence concerns the gene PDE4B and chronic obstructive pulmonary disease.